Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017)
Eledon Pharmaceuticals (ELDN) reported Amortizatization of Intangibles of -$1000.0 for Q1 2017, up 97.3% on a YoY basis from -$506.85 in Q1 2016, and up 83.33% quarter-over-quarter from -$6000.0 in Q4 2016.
Eledon Pharmaceuticals (ELDN) Amortizatization of Intangibles (2015 - 2017) Analysis & Trends
Eledon Pharmaceuticals has reported Amortizatization of Intangibles for 3 years, with the latest figure at -$1000.0 in Q1 2017.
- For the quarter ending Q1 2017, Amortizatization of Intangibles rose 97.3% year-over-year to -$1000.0; the trailing twelve-month figure through Mar 2017 stood at -$79000.0 (changed N/A YoY), and the FY2024 full-year result was $359000.0, down 4.01% from the prior year.
- Amortizatization of Intangibles for Q1 2017 stood at -$1000.0, up from -$6000.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was -$1000.0 in Q1 2017, with the low at -$39000.0 in Q2 2016.
- Historically, Amortizatization of Intangibles has averaged -$26714.3 across 3 years, with a median of -$33000.0 in 2015.
- Annual changes were most pronounced in 2016 — Amortizatization of Intangibles changed 0.0% — and 2017, when it soared 97.3%.
- Eledon Pharmaceuticals' Amortizatization of Intangibles stood at -$38000.0 in 2015, then soared by 84.21% to -$6000.0 in 2016, then surged by 83.33% to -$1000.0 in 2017.
- The last three Amortizatization of Intangibles figures came in at -$1000.0 (Q1 2017), -$6000.0 (Q4 2016), and -$33000.0 (Q3 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Eledon Pharmaceuticals | 401.35 Mn | 185.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -1,000.00 |
| Mar 31, 2017 | -1,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Dec 31, 2016 | -6,000.00 |
| Sep 30, 2016 | -33,000.00 |
| Sep 30, 2016 | -33,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Jun 30, 2016 | -39,000.00 |
| Mar 31, 2016 | -37,000.00 |
| Mar 31, 2016 | -37,000.00 |
| Dec 31, 2015 | -38,000.00 |
| Dec 31, 2015 | -38,000.00 |
| Sep 30, 2015 | -33,000.00 |
| Sep 30, 2015 | -33,000.00 |